Mediven, Tune Protect and MyDocLabTM today officially launched their community care collaboration which offers COVID-19 insurance coverage and diagnostic screening via mobile app, MyDocLabTM.
The unique tripartite collaboration is touted as a first in the market with the merging of innovation, insurance protection and diagnostic screening. Mediven® test kit users can now enjoy the added bonus of insurance coverage at no extra costs.
Mediven® Executive Director, En Ariff Ismail explained, “This initiative is timely as the nation moves into the endemic phase and communities learn to live with the virus. Our Community Care Collaboration is designed to offer peace of mind and double protection; all within convenience of one’s mobile phone. Users of Mediven®’s ProDetect® self-test kits will receive an allowance if tested positive for COVID-19 Category three and above. Users will also be protected with accidental death and total permanent disability benefits. The coverage is valid for 14 days upon submission of their test results via MyDocLab.
Mediven®, a Penang-based medical diagnostic company which develops, manufactures, and markets advanced high quality clinical diagnostic molecular and rapid tests, is the manufacturer of ProDetect® self-test kits, approved by the Malaysia Medical Device Authority (MDA).
Explaining Tune Protect’s involvement, Group CEO, Mr Rohit Nambiar commented, “Tune Protect’s partnership in this collaboration is very much in line with our business aspirations. We aim to make insurance simplified and accessible for everyone. With the power of technology and through this collaboration, we are one step closer to providing protection anytime, anywhere at the convenience of the fingertips. We are truly honoured to be the official insurance partner to offer value added insurance protection to Mediven® Covid test kit users which will be a relief for Covid positive patients.”
Mediven® Operations Director, Dr Lim Li Sze, added, “Protection is key in everyone’s mind as we go through this trying and prolonged health challenge. This community care collaboration allows us to extend double protection in terms of diagnostic screening and insurance coverage to protect ourselves, our families, our workplaces and the community at large.”
MyDocLabTM users can also tap on the multi-featured digital platform to conduct virtually-supervised screenings for Medical Device Authority (MDA) approved test kits, made possible through partnerships with select private clinics and laboratories. Travellers arriving in Malaysia who must undergo a professionally administered RTK within 24 hours of arrival can also opt to perform their self-test within the comforts of their home or quarantine centre via the app. Same day result anytime, anywhere are guaranteed.
In addition, the app also allows bookings for real-time PCR, rapid antigen and post-vaccination neutralising antibody tests at clinics and laboratories. Travellers may also purchase travel insurance with a COVID-19 cover as required by the Malaysian government.
Additionally, Human Resource managers of corporate companies will also find the MyDocLabforWork feature helpful as it essentially helps companies effectively manage and track their employees’ health status through a hassle-free process.
Dr Lim said that they are working closely with partner pharmacies to educate consumers on the double protection of insurance and diagnostic screening offered to assist them in these endemic times. Mediven® ProDetect® COVID-19 test kits (saliva or nasal formats) are available in most major chain pharmacies and retails outlets such as Alpro, AMPM, CARiNG, Georgetown, Watsons, Wellings, Be Pharmacy and 7-Eleven.